Duality of interest JJM has participated on advisory boards or has been invited as speaker by Astra Zeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Eli Lilly & Co., Intarcia Therapeutics Inc., MSD, Novo Nordisk, Novartis and Sanofi
Adhering to the discipline of this cadence may take a bit more effort but offers an alternative to the reliance on drugs
Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing
Over-the-counter simethicone (Gas-X, Mylicon) can reduce gas bubbles in the gastrointestinal tract, though evidence for its effectiveness is limited
When validated in randomized clinical trials, only a few drugs have shown efficacy on NASH liver histology and/or fibrosis